AstraZeneca Pharma India Q4 net profit up 2.57% at Rs 27.98 cr
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/05/60746c8dccac70a3fd0db5ef637084df.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
The company reported standalone net profit of Rs 27.98 crore for the quarter ended March 31, 2022 as compared to Rs 27.28 crore in the same period last year, registering a year-on-year growth of 2.57 per cent. Net revenue of the company rose moderately by 10.32 per cent at Rs 231.96 crore in January-March quarter of this fiscal as against Rs 210.26 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 14.22 per cent to Rs 194.00 crore from Rs 169.85 crore in year ago period.
Other Income grew by 44.31 per cent at Rs 3.68 crore versus (Mar'21 Rs 2.55 crore). Operating Profit slipped by 6.06 per cent to Rs 37.96 crore as against Rs 40.41 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 14.88 per cent in March quarter. Interest declined by 25.00 per cent y-o-y to Rs 0.21 crore, while Taxation decreased by 5.33 per cent at Rs 9.05 crore (Mar'21 Rs 9.56 crore).
![](https://portfolio.investmentguruindia.com/uploads/news/Clean Science and Technology.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Somany logo.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/startup.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Srinivas Narayanan.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Mongolia.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/nitingadkari37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/jul03v68_wcHr0zT.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/IT Sector03.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Bharti Airtel Ltd.jpg)
Top News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/06/0343072ab3a9dc7bff4b4225ca935c90.jpg)
JB Chemicals & Pharmaceuticals gains on launching medicated nicotine lozenges to help quit s...
Tag News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/07/289f32ddbe6a2a10a030a00631b82f66.jpg)
AstraZeneca Pharma soars on receiving permission from DCGI for Dapagliflozin Tablets
![AstraZeneca Pharma rises on getting permission to Import for sale and distribution of Trastuzumab deruxtecan solution](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/05/c8b521225fd6db48a5be95dd9c981c36.jpg)
![AstraZeneca Pharma rises on getting Import, Market permission in Form CT-20 from DCGI for Olaparib Film-Coated tablets](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/08/649aaa1f3ac3851abe3135d2d8e90f1b.png)
![Astrazeneca Pharma moves up on getting import and market permission for Selumetinib 10 Mg & 25 Mg Capsule](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/09/ec6c51a2dd27c9284fe8bd6b2a33e40b.png)